Investors might want to bet on DarioHealth Corp. (DRIO), as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This upgrade is essentially a reflection of an upward trend in earnings ...

DarioHealth Corp. (DRIO) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). An upward trend in earnings estimates -- one of the most powerful forces ...

Teladoc TDOC stock recently cratered to a new 52 week low following it’s Q1 report. Some of it’s shortfall was attributed by management to longer sales cycles in the insurer and employer space in ...

My trading experience includes over twenty five years of intense investment analysis, trend analysis and deep level due diligence studies. My interest is to find small company opportunities that have ...

DarioHealth has experienced a disappointing year with stalled revenue growth and a decline in new customer wins. However, H2/23 and FY24 are expected to bring improved financials, including revenue ...

DRIO is trading in the middle of its 52-week range and below its 200-day simple moving average. Price change The price of DRIO shares has decreased $0.17 since the market last closed. This is a 1.45% ...

DarioHealth Corp. (NASDAQ: DRIO) said Thursday that its board has begun a strategic review following unsolicited interest from potential partners. The New York-based digital health company, which ...

NASDAQ, Inc. short interest is available by issuer for the past 12 months and updated twice a month. Short interest data is reported on mid-month and end-of-month settlement dates. It is then released ...

Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets. Analysts evaluate the stock’s expected performance in a given time period based on their ...